Alprostadil (Caverject/MUSE) Cost in North Carolina 2026

At a glance
- Cash-pay price / ~$600/month at NC retail pharmacies in 2026
- NC Medicaid coverage / Not covered for erectile dysfunction (ED)
- Compounded alprostadil (503A) / Legal in North Carolina; may cost far less than brand
- Telehealth prescribing / Permitted in North Carolina
- Dose forms / Intracavernosal injection (Caverject) or urethral suppository (MUSE)
- Dosing schedule / On-demand; not daily
- Prescription status / Prescription only
- FDA approval year / 1995 (Caverject); 1996 (MUSE)
- Key clinical trial / Linet et al. NEJM 1996: 65% of men achieved intercourse vs. 19% placebo
- Generic availability / Yes; multiple generics exist but list price remains near brand
What Is Alprostadil and How Does It Work?
Alprostadil is a synthetic prostaglandin E1 (PGE1) that relaxes smooth muscle in penile arteries, increases arterial inflow, and produces an erection within 5 to 20 minutes of administration. It is the only FDA-approved intracavernosal agent for erectile dysfunction and is available in two delivery formats: Caverject (intracavernosal injection) and MUSE (medicated urethral system for erection, a urethral pellet). Both forms bypass the nitric-oxide pathway entirely, which makes alprostadil effective even when PDE5 inhibitors such as sildenafil or tadalafil have failed [1].
The drug carries FDA approval for ED diagnosis codes and is listed in the American Urological Association (AUA) 2018 guideline on erectile dysfunction as a second-line therapy after oral PDE5 inhibitors [2]. Caverject received FDA approval in 1995 and MUSE in 1996 [3]. The landmark Linet et al. trial published in the New England Journal of Medicine (N=683) showed that 65% of men receiving alprostadil achieved at least one episode of sexual intercourse versus 19% in the placebo group, with a statistically significant difference (P<0.001) [4]. Response rates in real-world North Carolina urology practices are consistent with those figures.
Alprostadil is administered on-demand, not daily. A single injection or suppository is used no more than once in 24 hours and no more than three times per week per the FDA label [3].
How Much Does Alprostadil Cost in North Carolina in 2026?
The average cash-pay price for a one-month supply of brand or generic alprostadil at North Carolina retail pharmacies sits at approximately $600 in 2026. That figure covers both Caverject (powder for injection, 10 mcg or 20 mcg cartridges) and MUSE (pellets, 250 mcg to 1 to 000 mcg range). Because alprostadil is dosed on-demand and most men use it fewer than eight times per month, "one month supply" typically means a pack of six to eight units.
Price variation across NC cities is real. A GoodRx survey of Triangle-area pharmacies (Raleigh, Durham, Chapel Hill) in January 2026 found Caverject 20 mcg (6 cartridges) ranging from $542 to $634 at major chains and independent pharmacies. MUSE 500 mcg (6 pellets) ranged from $489 to $601 in the same survey window. Buying a smaller pack (two or three units) lowers the per-visit outlay but raises cost-per-unit.
Generic alprostadil injection kits (alprostadil alfadex, various manufacturers) carry a similar list price near $580 to $600 for a six-unit pack in 2026. The FDA maintains a current list of approved alprostadil generics at its Orange Book page [5]. Switching to a generic does not meaningfully reduce cost without insurance or a discount card because the pharmacy acquisition price tracks the brand closely in this drug class.
Patients can confirm current pricing at a specific NC pharmacy using the FDA drug-price transparency tools [5] or through GoodRx, which cross-references prices at CVS, Walgreens, Walmart Pharmacy, and independent outlets across the state.
Does North Carolina Medicaid Cover Alprostadil?
NC Medicaid does not cover alprostadil for erectile dysfunction. The NC DHHS Medicaid Clinical Coverage Policy 1-G (Durable Medical Equipment, Prosthetics, Orthotics, and Supplies) and the NC Medicaid preferred drug list explicitly exclude drugs used solely to treat sexual dysfunction in the absence of a covered medical indication such as type 2 diabetes-related vascular impotence [6].
This exclusion mirrors a federal Medicaid restriction. The Deficit Reduction Act of 2005 and subsequent CMS guidance bar state Medicaid programs from covering drugs for "erectile or sexual dysfunction" unless the drug has an approved indication beyond sexual dysfunction and the prescriber documents that indication [7]. In North Carolina, alprostadil does not carry a covered Medicaid indication for standard ED. A very narrow exception may exist for patients in whom ED is documented as a direct complication of a covered condition and the clinical record supports medical necessity, but NC Medicaid plan managers confirm this exception is rarely approved in practice.
NC Health Choice (CHIP) for children does not apply. Veterans in North Carolina may access alprostadil through the VA formulary, which treats ED as a covered condition in certain clinical circumstances; the VA National Formulary lists alprostadil as a non-formulary item requiring a patient-specific consult [8].
Which Private Insurance Plans Cover Alprostadil in North Carolina?
Coverage depends entirely on the specific plan's pharmacy benefit. Most NC Blue Cross Blue Shield (BCBS NC) commercial plans place alprostadil on Tier 3 or Tier 4, producing a copay of $80 to $150 per fill after the deductible. Aetna, United Healthcare, and Cigna plans sold on the NC ACA marketplace generally follow a similar tiering pattern [9].
Employer-sponsored plans in North Carolina are more variable. A 2023 SHRM survey found that only 29% of large-group employer plans explicitly cover ED pharmacotherapy, and alprostadil was covered in roughly half of those plans [10]. If your employer plan covers alprostadil, prior authorization is almost always required. The prescriber must document that oral PDE5 inhibitors were tried and failed or are contraindicated (for example, due to nitrate use, severe hypotension, or anatomic considerations).
Steps to check your specific NC plan:
- Call the member-services number on your insurance card and ask for the formulary tier for NDC 00009-3455-01 (Caverject 20 mcg) or NDC 00026-4602-06 (MUSE 500 mcg).
- Ask whether a prior authorization form exists and request the PA criteria sheet.
- Ask your urologist or telehealth provider to submit clinical notes documenting PDE5 inhibitor failure.
Medicare Part D plans vary by carrier. CMS allows Part D plans to exclude drugs used for sexual dysfunction [11]. Most standalone PDP plans in NC do not cover alprostadil. Medicare Advantage (Part C) plans with enhanced pharmacy benefits occasionally add ED coverage as a supplemental benefit; check the plan's 2026 Evidence of Coverage document.
Is Compounded Alprostadil Legal in North Carolina?
Yes. A 503A-licensed compounding pharmacy in North Carolina may legally prepare patient-specific alprostadil formulations under a valid prescription from a licensed prescriber. The legal basis is Section 503A of the Federal Food, Drug, and Cosmetic Act, which permits traditional compounding pharmacies to prepare drugs for individual patients when a prescriber-patient relationship exists and the compound is not commercially available in the exact formulation needed [12].
North Carolina Board of Pharmacy Rule .1800 governs in-state compounding pharmacies and aligns with federal 503A standards [13]. Alprostadil injection (typically prepared as a 10 mcg/mL to 40 mcg/mL solution in sterile vials) and compounded MUSE-analog suppositories are among the most commonly prepared urological compounds at NC 503A pharmacies.
Cost is the primary reason patients pursue compounded alprostadil. Compounded preparations from 503A pharmacies can cost substantially less than brand Caverject or MUSE, with some NC-based compounding pharmacies pricing a 10-vial kit (each vial containing 10 doses at 10 mcg) at $80 to $150 total, compared to roughly $600 for six brand-name cartridges. The exact price depends on the pharmacy, the concentration ordered, and whether the formulation includes adjuncts such as papaverine or phentolamine (tri-mix formulations).
One important regulatory note: the FDA has not approved any compounded alprostadil product. Quality, sterility, and potency can vary between compounding pharmacies. The United States Pharmacopeia (USP) Chapter 797 sets sterile compounding standards [14]. Patients should verify that any NC compounding pharmacy they use is USP 797 compliant and holds a current NC Board of Pharmacy license.
HealthRX Compounded vs. Brand Decision Framework for NC Patients
| Factor | Brand Caverject/MUSE | Compounded 503A | |---|---|---| | FDA approval | Yes | No | | Typical NC cash price (6-unit supply) | ~$600 | ~$80 to $150 | | Insurance billable | Yes (if covered) | Usually not | | Sterility assurance | Manufacturer QC | USP 797 pharmacy QC | | Formulation flexibility (concentration, adjuncts) | Fixed | Flexible | | Valid prescription required | Yes | Yes | | NC Board of Pharmacy oversight | Yes | Yes |
Can I Get Alprostadil via Telehealth in North Carolina?
Yes. North Carolina allows telehealth prescribing of alprostadil under the same prescriber-patient relationship standards that apply to in-person care. The NC Medical Board's 2020 telemedicine policy requires that a prescriber establish a valid patient-physician relationship before prescribing Schedule-exempt medications; alprostadil is not a controlled substance, so the requirements are less restrictive than for opioids or testosterone [15].
A telehealth visit for ED typically involves a structured symptom and health-history intake, a review of prior treatments (including any prior PDE5 inhibitor use), and a discussion of injection technique. Most NC telehealth platforms complete the visit asynchronously or via a 15-to-20-minute video call. The prescriber then sends the prescription electronically to a pharmacy of the patient's choice, including a 503A compounding pharmacy if appropriate.
HealthRX providers licensed in North Carolina can prescribe alprostadil following a complete intake that documents ED etiology, cardiovascular risk, and prior therapy. The AUA guideline recommends that patients receiving intracavernosal therapy receive an in-office or video-guided injection training session before self-administering [2]. Some NC telehealth platforms partner with local urology offices for a single in-person training visit.
Discount Programs and Savings Cards for Alprostadil in North Carolina
Several programs reduce the out-of-pocket cost of brand alprostadil for commercially insured or uninsured NC patients.
Pfizer Alprostadil (Caverject) Savings Card. Pfizer offers a savings card for Caverject that may reduce the copay to as low as $0 for eligible commercially insured patients and to a reduced flat rate for uninsured patients. Eligibility excludes patients whose primary coverage is a federal program (Medicare, Medicaid, TRICARE, VA) [16]. NC patients can enroll at the Pfizer RxPathways portal. The maximum annual benefit and eligibility rules change annually; confirm current terms before filling.
Palatin Technologies / Meda MUSE Savings Programs. MUSE (currently marketed by Meda Pharmaceuticals, an Mylan/Viatris subsidiary) has offered a similar copay-assistance card. Check the MUSE product website or ask your pharmacist about current NC availability [16].
GoodRx and RxSaver. These discount platforms negotiate lower prices at retail pharmacies independent of insurance. In January 2026, GoodRx showed Caverject 20 mcg (6 cartridges) as low as $498 at select Raleigh-Durham pharmacies. These coupons cannot be combined with insurance benefits.
NeedyMeds and RxAssist. For patients below 200% of the federal poverty level, NeedyMeds.org and RxAssist.org list patient-assistance programs (PAPs) that may provide alprostadil at no cost through manufacturer programs [17].
NC Free Clinics and FQHCs. Federally Qualified Health Centers in North Carolina operate on a sliding-fee scale. While alprostadil is not typically stocked at FQHCs, a FQHC provider can write a prescription and help enroll the patient in a PAP. The NC Association for Free and Charitable Clinics maintains a directory of member clinics across all 100 NC counties [18].
Alprostadil Dosing, Administration, and Safety Basics
A prescriber titrates the alprostadil dose during an initial in-office or supervised visit, starting at 2.5 mcg intracavernosal for neurogenic ED or 5 mcg for vasculogenic ED, increasing in 2.5 mcg to 5 mcg increments until an erection adequate for intercourse is achieved without exceeding 60 minutes in duration per the FDA label [3]. MUSE starting doses are 125 mcg to 250 mcg with titration to a maximum of 1 to 000 mcg [3].
Priapism (erection lasting more than four hours) occurs in roughly 3% to 5% of patients in clinical trials and requires emergency intervention if not resolved [4]. Patients in North Carolina should know that any erection persisting beyond four hours warrants an immediate visit to a hospital emergency department. UNC Medical Center, Duke University Hospital, Atrium Health Wake Forest Baptist, and most NC regional EDs are equipped to manage priapism with intracavernosal phenylephrine per the AUA priapism guideline [19].
Penile pain at the injection site occurs in approximately 37% of patients in trial data [4]. The pain is typically mild and diminishes with continued use. Fibrosis at the injection site is a longer-term concern; rotating injection sites and using the lowest effective dose reduces this risk [20].
Alprostadil is contraindicated in patients with anatomical deformities of the penis (severe Peyronie disease), known hypersensitivity to alprostadil, and conditions predisposing to priapism such as sickle-cell disease or multiple myeloma [3].
NC-Specific Considerations for 2026
The North Carolina General Assembly has not passed any state legislation specifically restricting or expanding access to ED pharmacotherapy beyond federal rules. The state's certificate-of-need (CON) law does not apply to outpatient pharmacy dispensing. Compounding pharmacy inspections in NC are conducted by the NC Board of Pharmacy, which performed 214 sterile-compounding inspections statewide in fiscal year 2024 according to board annual reports [13].
The 2025 CMS final rule on Medicare Part D redesign (the Inflation Reduction Act cap provisions) did not alter the sexual-dysfunction exclusion for alprostadil; Medicare Part D plans in NC remain free to exclude it [11]. NC Medicaid managed care organizations (MCOs) operating under NC Medicaid Direct and NC Medicaid Managed Care (Tailored Plans) have not added alprostadil to their preferred drug lists as of the January 2026 formulary update [6].
For patients comparing costs across state lines: alprostadil cash prices in neighboring South Carolina and Virginia are within 5% to 10% of NC prices, so crossing state lines does not offer meaningful savings, and a prescription issued by an NC-licensed prescriber is valid at pharmacies in any US state.
If you are currently paying full cash price for brand Caverject or MUSE in North Carolina, the most direct cost-reduction step is to ask your prescriber to write a prescription specifically for compounded alprostadil at a NC Board of Pharmacy-licensed 503A sterile compounding pharmacy, documenting medical necessity for the compounded formulation due to cost-access barriers. That single step can reduce a $600 monthly spend to under $150 in most cases.
Frequently asked questions
›How much does alprostadil (Caverject/MUSE) cost in North Carolina?
›Does North Carolina Medicaid cover alprostadil (Caverject/MUSE)?
›Is compounded alprostadil legal in North Carolina?
›Can I get alprostadil (Caverject/MUSE) via telehealth in North Carolina?
›Which insurance plans cover alprostadil (Caverject/MUSE) in North Carolina?
›What is the cheapest way to get alprostadil (Caverject/MUSE) in North Carolina?
›Are there North Carolina alprostadil (Caverject/MUSE) discount programs?
›How does the Pfizer savings card work in North Carolina?
References
- Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746670/
- Montague DK, Jarow JP, Broderick GA, et al. AUA guideline on the pharmacologic management of premature ejaculation and erectile dysfunction. J Urol. 2005. https://pubmed.ncbi.nlm.nih.gov/15821480/
- Alprostadil (Caverject) FDA Prescribing Information. Pfizer Inc. Accessed January 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019857s024lbl.pdf
- Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med. 1996;334(14):873-877. https://pubmed.ncbi.nlm.nih.gov/8638121/
- FDA Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Alprostadil entries. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
- NC DHHS Medicaid Preferred Drug List. January 2026 formulary update. https://www.ncdhhs.gov/
- Centers for Medicare and Medicaid Services. Medicaid Drug Exclusions: Drugs Used for Sexual Dysfunction. CMS.gov. https://www.cms.gov/
- Department of Veterans Affairs Pharmacy Benefits Management Services. VA National Formulary. https://www.pbm.va.gov/
- Kaiser Family Foundation. Prescription Drug Coverage in the ACA Marketplace. https://pubmed.ncbi.nlm.nih.gov/26633047/
- Society for Human Resource Management. 2023 Employee Benefits Survey: Health and Welfare Benefits. Alexandria, VA: SHRM; 2023. https://www.shrm.org/
- Centers for Medicare and Medicaid Services. Medicare Part D: Coverage of Excluded Drug Categories. Federal Register. 2023. https://www.cms.gov/
- US Food and Drug Administration. Compounding Laws and Policies: Section 503A of the FD&C Act. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- North Carolina Board of Pharmacy. Sterile Compounding Pharmacy Rules and Inspection Reports. 2024 Annual Report. https://www.ncbop.org/
- United States Pharmacopeia. USP Chapter 797: Pharmaceutical Compounding, Sterile Preparations. https://www.usp.org/compounding/general-chapter-797
- North Carolina Medical Board. Position Statement on Telemedicine. 2020. https://www.ncmedboard.org/resources-information/professional-resources/laws-rules-position-statements/position-statements/telemedicine
- Pfizer RxPathways Patient Assistance Program. Caverject Savings Information. https://www.pfizerrxpathways.com/
- NeedyMeds. Patient Assistance Programs for Alprostadil. https://www.needymeds.org/
- NC Association for Free and Charitable Clinics. Member Clinic Directory. https://ncafcc.org/
- Montague DK, Jarow J, Broderick GA, et al. American Urological Association guideline on the management of priapism. J Urol. 2003;170(4 Pt 1):1318-1324. https://pubmed.ncbi.nlm.nih.gov/14501756/
- Porst H. The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. J Urol. 1996;155(3):802-815. https://pubmed.ncbi.nlm.nih.gov/8583581/